We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Sanofi | NASDAQ:SNY | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.46 | -0.93% | 49.00 | 49.00 | 49.95 | 49.595 | 48.97 | 49.48 | 1,113,911 | 01:00:00 |
From May 2019 to May 2024
By Inti Landauro
PARIS--French pharmaceutical giant Sanofi SA (SAN.FR) Wednesday said it has teamed up with South Korea's SK Chemicals Co. (006120.SE) to develop a pneumococcal vaccine.
Sanofi will make an up-front payment of $23 million to SK Chemicals. Both companies will develop the vaccine together, with SK Chemicals producing it in a factory in South Korea.
The market for vaccines against diseases caused by streptococcus pneumoniae, such as pneumonia, meningitis and febrile bacteraemia, is worth $4 billion, Sanofi said in a statement.
Write to Inti Landauro at inti.landauro@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
